Heidi Johnsen
Papers
1
Total Citations
5
H-Index
1
About
Heidi Johnsen is a researcher whose work bridges microbiology and high-throughput screening, with a focus on combating fungal infections. Her primary research areas include the development of innovative assay technologies for pathogenic fungi, particularly *Candida albicans*, and the exploration of bioactive compounds for antifungal applications. Johnsen’s major contribution is the creation of a high-throughput robotic microtiter plate-based screening assay that replicates the filamentous biofilm growth of *C. albicans* found in vivo—a critical advancement for studying drug efficacy in conditions that mimic real infections. Her most-cited paper, “High-throughput assay for effect screening of amphotericin B and bioactive components on filamentous *Candida albicans*” (2022, 5 citations), demonstrates this assay’s utility by evaluating the effects of amphotericin B and nutraceutical components, offering a scalable tool for antifungal drug discovery. While her citation count is modest, the novelty of her method holds significant promise for accelerating research on biofilm-targeting therapies. Johnsen’s work is particularly notable for its potential to reduce reliance on animal models and improve the translational relevance of *in vitro* studies, marking her as an emerging contributor to antifungal pharmacology and assay development.
Research Focus
Key Achievements
Top Papers
- 1